Dermatophagoides spp. hypoallergens design: what has been achieved so far?

References

• Enilari O, Sinha S. The global impact of asthma in adult populations. Ann Glob Health. 2019 Jan 22;85(1):1–7.
   PubMed Web of Science ®Google Scholar
• Pawankar R, Canonica GW, Holgate ST, et al. World allergy organization (WAO) white book on allergy. United Kingdom: WAO; 2013. English.
   Google Scholar
• Baumann LM, Romero KM, Robinson CL, et al. Prevalence and risk factors for allergic rhinitis in two resource-limited settings in Peru with disparate degrees of urbanization. Clin Exp Allergy. 2015 Jan;45(1):192–199.
   PubMed Web of Science ®Google Scholar
• Cruz AA, Stelmach R, Ponte EV. Asthma prevalence and severity in low-resource communities. Curr Opin Allergy Clin Immunol. 2017 June;17(3):188–193.
   PubMed Web of Science ®Google Scholar
• Brozek G, Lawson J, Szumilas D, et al. Increasing prevalence of asthma, respiratory symptoms, and allergic diseases: four repeated surveys from 1993–2014. Respir Med. 2015 Aug;109(8):982–990.
   PubMed Web of Science ®Google Scholar
• Alcantara-Neves NM, Veiga RV, Ponte JC, et al. Dissociation between skin test reactivity and anti-aeroallergen IgE: determinants among urban Brazilian children. PLoS One. 2017;12(3):e0174089.
   PubMed Web of Science ®Google Scholar
• Figueiredo CA, Amorim LD, Alcantara-Neves NM, et al. Environmental conditions, immunologic phenotypes, atopy, and asthma: new evidence of how the hygiene hypothesis operates in Latin America. J Allergy Clin Immunol. 2013 Apr;131(4):1064–1068 e1.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Vaca MG, Chico ME, et al. Rural to urban migration is associated with increased prevalence of childhood wheeze in a Latin-American city. BMJ Open Respir Res. 2017;4(1):e000205.
   PubMed Web of Science ®Google Scholar
• Soegiarto G, Abdullah MS, Damayanti LA, et al. The prevalence of allergic diseases in school children of metropolitan city in Indonesia shows a similar pattern to that of developed countries. Asia Pac Allergy. 2019 Apr;9(2):e17.
   PubMed Web of Science ®Google Scholar
• Miller JD. The role of dust mites in allergy. Clin Rev Allergy Immunol. 2019 Dec;57(3):312–329.
   Web of Science ®Google Scholar
• Calderon MA, Linneberg A, Kleine-Tebbe J, et al. Respiratory allergy caused by house dust mites: what do we really know? J Allergy Clin Immunol. 2015 July;136(1):38–48.
   PubMed Web of Science ®Google Scholar
• Acevedo N, Zakzuk J, Caraballo L. House dust mite allergy under changing environments. Allergy Asthma Immunol Res. 2019 July;11(4):450–469.
   PubMed Web of Science ®Google Scholar
• Thomas WR. Hierarchy and molecular properties of house dust mite allergens. Allergol Int. 2015 Oct;64(4):304–311.
   PubMed Web of Science ®Google Scholar
• Huang FL, Liao EC, Yu SJ. House dust mite allergy: its innate immune response and immunotherapy. Immunobiology. 2018 Mar;223(3):300–302.
   PubMed Web of Science ®Google Scholar
• Valenta R, Campana R, Focke-Tejkl M, et al. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: lessons from the past and novel mechanisms of action for the future. J Allergy Clin Immunol. 2016 Feb;137(2):351–357.
   PubMed Web of Science ®Google Scholar
• Yasir M, Sonthalia S. Corticosteroid adverse effects. Treasure Island (FL): StatPearls; 2019.
   Google Scholar
• Criado PR, Criado RF, Maruta CW, et al. Histamine, histamine receptors and antihistamines: new concepts. An Bras Dermatol. 2010 Mar–Apr;85(2):195–210.
   PubMed Web of Science ®Google Scholar
• Billington CK, Penn RB, Hall IP. beta2 agonists. Handb Exp Pharmacol. 2017;237:23–40.
   PubMedGoogle Scholar
• Silva ES, Pinheiro CS, Quintella CM, et al. Advances in patent applications related to allergen immunotherapy. Expert Opin Ther Pat. 2016 June;26(6):657–668.
   PubMed Web of Science ®Google Scholar
• Ferreira F, Wolf M, Wallner M. Molecular approach to allergy diagnosis and therapy. Yonsei Med J. 2014 July;55(4):839–852.
   PubMed Web of Science ®Google Scholar
• Noon L. Prophylactic inoculation against hay fever. Int Arch Allergy Appl Immunol. 1953;4(4):285–288.
   PubMedGoogle Scholar
• Konradsen J, Arvidsson M. Allergen-specific immunotherapy provides long-lasting symptom relief. Lakartidningen. 2016 Apr 4;113:1–5.
   Google Scholar
• Marogna M, Spadolini I, Massolo A, et al. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol. 2010 Nov;126(5):969–975.
   PubMed Web of Science ®Google Scholar
• Mrkic I, Minic R, Popovic D, et al. Newly designed hemagglutinin-Der p 2 chimera is a potential candidate for allergen specific immunotherapy. Life Sci. 2018 Nov 15;213:158–165.
   PubMed Web of Science ®Google Scholar
• Saarne T, Neimert-Andersson T, Gronlund H, et al. Treatment with a Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy. Allergy. 2011 Feb;66(2):255–263.
   PubMed Web of Science ®Google Scholar
• Eichhorn S, Horschlager A, Steiner M, et al. Rational design, structure-activity relationship, and immunogenicity of hypoallergenic Pru p 3 variants. Mol Nutr Food Res. 2019;17:e1900336.
   Google Scholar
• Calderon MA, Bousquet J, Canonica GW, et al. Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: time for a change? J Allergy Clin Immunol. 2017 July;140(1):41–52.
   PubMed Web of Science ®Google Scholar
• Nemet S, Baric M, Bencic F, et al. Comparative technology assessment using patent evaluation. 2018.
   Google Scholar
• Ignat V. Modern evaluation of patents. 2016;147:1–7.
   Google Scholar
• Chan SL, Ong ST, Ong SY, et al. Nuclear magnetic resonance structure-based epitope mapping and modulation of dust mite group 13 allergen as a hypoallergen. J Immunol. 2006 Apr 15;176(8):4852–4860.
   PubMed Web of Science ®Google Scholar
• Kulwanich B, Thanyaratsrisakul S, Jirapongsananuruk O, et al. Effects of Ser47-point mutation on conformation structure and allergenicity of the allergen of Der p 2, a major house dust mite allergen. Allergy Asthma Immunol Res. 2019 Jan;11(1):129–142.
   PubMed Web of Science ®Google Scholar
• Pulsawat P, Piboonpocanun S, Sirivichayakul S, et al. Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergen. J Investig Allergol Clin Immunol. 2010;20(7):582–590.
   PubMed Web of Science ®Google Scholar
• Reginald K, Chew FT. Conformational IgE epitope mapping of Der p 2 and the evaluations of two candidate hypoallergens for immunotherapy. Sci Rep. 2018 Feb 21;8(1):3391.
   PubMedGoogle Scholar
• Li CP, Zhao BB, Zhan XD. Immunotherapeutic effect of dermatophagoides pteronyssinus Group 1 Allergen T cell epitope peptide against allergic asthma in mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2016 June;34(3):214–219.
   PubMedGoogle Scholar
• Ai C, Zhang Q, Ding J, et al. Suppression of dust mite allergy by mucosal delivery of a hypoallergenic derivative in a mouse model. Appl Microbiol Biotechnol. 2015 May;99(10):4309–4319.
   PubMed Web of Science ®Google Scholar
• Xiao-Dong Z, Bin-Bin D, Yong H, et al. A specific immune therapeutic effect of Der p2 T cell epitope vaccine on asthma mice. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2016 Dec 12;29(1):59–63.
   PubMedGoogle Scholar
• Zhao J, Li C, Zhao B, et al. Construction of the recombinant vaccine based on T-cell epitope encoding Der p1 and evaluation on its specific immunotherapy efficacy. Int J Clin Exp Med. 2015;8(4):6436–6443.
   PubMed Web of Science ®Google Scholar
• Asturias JA, Ibarrola I, Arilla MC, et al. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy. Clin Exp Allergy. 2009 July;39(7):1088–1098.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Weber M, Blatt K, et al. Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine. J Immunol. 2014 May 15;192(10):4867–4875.
   PubMed Web of Science ®Google Scholar
• Chen KW, Blatt K, Thomas WR, et al. Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy. J Allergy Clin Immunol. 2012 Aug;130(2):435–43 e4.
   PubMed Web of Science ®Google Scholar
• Bouaziz A, Walgraffe D, Bouillot C, et al. Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy. Clin Exp Allergy. 2015 Apr;45(4):823–834.
   PubMed Web of Science ®Google Scholar
• Li C, Li Q, Jiang Y. Efficacies of immunotherapy with polypeptide vaccine from ProDer f 1 in asthmatic mice. Int J Clin Exp Med. 2015;8(2):2009–2016.
   PubMed Web of Science ®Google Scholar
• Martinez D, Cantillo JF, Herazo H, et al. Characterization of a hybrid protein designed with segments of allergens from Blomia tropicalis and Dermatophagoides pteronyssinus. Immunol Lett. 2018;196:103–112.
   PubMed Web of Science ®Google Scholar
• Fanuel S, Tabesh S, Mokhtarian K, et al. Construction of a recombinant B-cell epitope vaccine based on a Der p1-derived hypoallergen: a bioinformatics approach. Immunotherapy. 2018 June;10(7):537–553.
   PubMed Web of Science ®Google Scholar
• Zhan X, Li C, Jiang Y, et al. Epitope-based vaccine for the treatment of Der F 3 allergy. Nutr Hosp. 2015 Dec 1;32(6):2763–2770.
   PubMed Web of Science ®Google Scholar
• Sun T, Yin K, Wu LY, et al. A DNA vaccine encoding a chimeric allergen derived from major group 1 allergens of dust mite can be used for specific immunotherapy. Int J Clin Exp Pathol. 2014;7(9):5473–5483.
   PubMed Web of Science ®Google Scholar
• Tan W, Zheng JH, Duong TMN, et al. A fusion protein of Derp2 allergen and flagellin suppresses experimental allergic asthma. Allergy Asthma Immunol Res. 2019 Mar;11(2):254–266.
   PubMed Web of Science ®Google Scholar
• Li C, Jiang Y, Guo W, et al. Production of a chimeric allergen derived from the major allergen group 1 of house dust mite species in Nicotiana benthamiana. Hum Immunol. 2013 May;74(5):531–537.
   PubMed Web of Science ®Google Scholar
• Zhao BB, Diao JD, Liu ZM, et al. Generation of a chimeric dust mite hypoallergen using DNA shuffling for application in allergen-specific immunotherapy. Int J Clin Exp Pathol. 2014;7(7):3608–3619.
   PubMed Web of Science ®Google Scholar
• Laimer J, Hofer H, Fritz M, et al. MAESTRO–multi agent stability prediction upon point mutations. BMC Bioinformatics. 2015 Apr;16(16):116.
   PubMedGoogle Scholar
• Shamji MH, Durham SR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J Allergy Clin Immunol. 2017 Dec;140(6):1485–1498.
   PubMed Web of Science ®Google Scholar
• Larche M. Mechanisms of peptide immunotherapy in allergic airways disease. Ann Am Thorac Soc. 2014 Dec;11(Suppl 5):S292–6.
   PubMedGoogle Scholar
• Curin M, Garib V, Valenta R. Single recombinant and purified major allergens and peptides: how they are made and how they change allergy diagnosis and treatment. Ann Allergy Asthma Immunol. 2017 Sept;119(3):201–209.
   PubMed Web of Science ®Google Scholar
• Curin M, Weber M, Thalhamer T, et al. Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction. Clin Exp Allergy. 2014 June;44(6):882–894.
   PubMed Web of Science ®Google Scholar
• Campana R, Marth K, Zieglmayer P, et al. Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: safety, effects, and mechanisms. J Allergy Clin Immunol. 2019 Mar;143(3):1258–1261.
   PubMed Web of Science ®Google Scholar
• Linhart B, Valenta R. Vaccine engineering improved by hybrid technology. Int Arch Allergy Immunol. 2004 Aug;134(4):324–331.
   PubMed Web of Science ®Google Scholar
• Sancho AI, Wallner M, Hauser M, et al. T cell epitope-containing domains of Ragweed Amb a 1 and Mugwort Art v 6 modulate immunologic responses in humans and mice. PLoS One. 2017;12(1):e0169784.
   PubMed Web of Science ®Google Scholar
• Hofer H, Asam C, Hauser M, et al. Tackling Bet v 1 and associated food allergies with a single hybrid protein. J Allergy Clin Immunol. 2017 Aug;140(2):525–533 e10.
   PubMed Web of Science ®Google Scholar
• Pichler U, Asam C, Weiss R, et al. The fold variant BM4 is beneficial in a therapeutic Bet v 1 mouse model. Biomed Res Int. 2013;2013:832404.
   PubMedGoogle Scholar
• Freidl R, Gstoettner A, Baranyi U, et al. Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy. J Allergy Clin Immunol. 2017 June;139(6):1897–1905 e1.
   PubMed Web of Science ®Google Scholar
• Marco AC, Sarnoff JD, deGrazia AW. Patent claims and patent scope. Res Policy. 2019;48:103790.
   PubMed Web of Science ®Google Scholar
• Sette A, Lundegaard C, Christensen L, et al., inventors; ALK-ABELLÓ AS assignee. Peptide combinations and uses thereof in treating dust mite allergy. United States of America. 2013.
   Google Scholar
• Asturias A, Santos M, Arilla C, inventors; ROXALL MEDICINA ESPAÑA SAL assignee. Fusion proteins. United Kingdom. 2016.
   Google Scholar
• Hafner RP, Paul L, Larche M, inventors; CIRCASSIA LTD assignee. Peptides for desensitization to allergen. United Kingdom. 2007.
   Google Scholar
• Hsu C-H, Su W-C, inventors; GENMONT BIOTECH INC assignee. Modified mite allergen and pharmaceutical uses thereof. United States of America. 2007.
   Google Scholar
• Asturias A, Arilla C, Garate A, et al., inventors; BIAL IND FARMACEUTICA AS, assignee. Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in treatment of allergies. Spain. 2008.
   Google Scholar
• Best E, Mcdermott M, inventors; Best, Elaine; Mcdermott, Martin, assignee. Variants of mite group 1 allergens for the treatment of house dust mite allergy. United States of America. 2004.
   Google Scholar
• Tsukui T, Tsujimoto H, Iwabuchi S, inventors; NIPPON ZENYAKU KOGYO CO LTD, assignee. Novel mite allergen. Japan. 2004.
   Google Scholar
• Puerta L, Caraballo L, Cantillo J, inventors; UNIV DE CARTAGENA; Puerta, Leonardo; Caraballo, Luis; Cantillo, José, assignee. Fusion proteins with representation of different allergens: vaccine proposal for mite allergies. Colombia. 2012.
   Google Scholar
• Koyanagi S, Kawatsu K, inventors; CHEMO SERO THERAPEUT RES INST; Koyanagi, Satoshi; Kawatsu, Kenjiro, assignee. Pharmaceutical composition containing stabilized altered mite principal allergen. Japan. 2004.
   Google Scholar
• Chen K-W, Vrtala S, Valenta R, inventors; BIOMAY AG; Chen, Kuan-Wei; Vrtala, Susanne; Valenta, Rudolf, assignee. Hypoallergenic polypeptides for the treatment of house dust mite allergy. Austria. 2010.
   Google Scholar
• Magnan A, Lair D, Vrtala S, inventors; INSERM INST SANTE RECH MED; UNIV NANTES; CT HOSPITALIER UNI NANTES; CENTRE NAT RECH SCIENT; UNIV WIEN MED, assignee. Polypeptides for use in the prophylactic treatment of allergic asthma. France. 2012.
   Google Scholar
• BIOMAY AG, Niespodziana K, Focke-Tejkl M, Chen K-W, et al. inventors Peptide carrier fusion proteins as allergy vaccines. Austria; 2011.
   Google Scholar
• Liu Z, Jiang Y, Li C. Design of a ProDer f 1 vaccine delivered by the MHC class II pathway of antigen presentation and analysis of the effectiveness for specific immunotherapy. Int J Clin Exp Pathol. 2014;7(8):4636–4644.
   PubMed Web of Science ®Google Scholar
• Branstetter L. Intellectual property rights, innovation and development: is asia different? Millennial Asia. 2017 Apr 01;8(1):5–25.
   Web of Science ®Google Scholar
• Fisch C, Block J, Sandner P. Chinese university patents: quantity, quality, and the role of subsidy programs. J Technol. 2016 Feb;41(1):60–84.
   Google Scholar
• Zeng DZ. Measuring the effectiveness of the Chinese innovation system: a global value chain approach. Int J Innov Stud. 2017 Jan 01;1(1):57–71.
   Google Scholar
• Adelman M A grace period and european patent law: it’s time for change. 2013.
   Google Scholar
• Dobson G. Understand what to do before your grace period ends. Pa Dent J (Harrisb). 2016 Jan–Feb;83(1):18–19.
   PubMedGoogle Scholar
• Roberts B. Why collaborating with industry can provide a career boost: springer nature limited; 2019 [ updated May;2019 June 16]. Available from: https://www.nature.com/articles/d41586-019-01572-1
   Google Scholar
• Bodas Freitas IM, Verspagen B. The motivations, institutions and organization of university-industry collaborations in the Netherlands. J Evol Econ. 2017;27(3):379–412.
   PubMed Web of Science ®Google Scholar
• Ehrismann D, Patel D. University - industry collaborations: models, drivers and cultures. Swiss Med Wkly. 2015;145:w14086.
   PubMed Web of Science ®Google Scholar
• Querido A, Salgueiro Lage CL, Guimarães Vasconcellos A. What is the destiny of patents of Brazilian universities? J Technol Manage Innov. 2011;6:46–57.
   Google Scholar
• Silva K, Vasconcellos A. Academic inventors and patent rights: structure of collaboration in academic patents and university patents in Brazil. Academia Revista Latinoamericana De Administración. 2018;10/01:21–33.
   Google Scholar
• Silva K, Vasconcellos A, Tonholo J, et al. Academic patenting in Brazil: the role of academic inventors in PCT patent applications – 2002–2012. Academia Revista Latinoamericana De Administración. 2017;11/11(30):529–546.
   Google Scholar
• Palacios-Callender M, Roberts SA. Scientific collaboration of Cuban researchers working in Europe: understanding relations between origin and destination countries. Scientometrics. 2018;117(2):745–769.
   PubMed Web of Science ®Google Scholar
• Leydesdorff L, Kogler DF, Yan B. Mapping patent classifications: portfolio and statistical analysis, and the comparison of strengths and weaknesses. Scientometrics. 2017 Sept 01;112(3):1573–1591.
   PubMed Web of Science ®Google Scholar
• Baqueiro T, Carvalho FM, Rios CF, et al. Dust mite species and allergen concentrations in beds of individuals belonging to different urban socioeconomic groups in Brazil. J Asthma. 2006 Mar;43(2):101–105.
   PubMed Web of Science ®Google Scholar
• Choi JS, Roh JY, Lee JR. Clinical availability of component-resolved diagnosis using microarray technology in atopic dermatitis. Ann Dermatol. 2014 Aug;26(4):437–446.
   PubMed Web of Science ®Google Scholar
• Mueller GA, Edwards LL, Aloor JJ, et al. The structure of the dust mite allergen Der p 7 reveals similarities to innate immune proteins. J Allergy Clin Immunol. 2010 Apr;125(4):909–917 e4.
   PubMed Web of Science ®Google Scholar
• Vidal C, Lojo S, Juangorena M, et al. Association between asthma and sensitization to allergens of dermatophagoides pteronyssinus. J Investig Allergol Clin Immunol. 2016;26(5):304–309.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Resch Y, Chen KW, et al. Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis. J Invest Dermatol. 2015 Jan;135(1):102–109.
   PubMed Web of Science ®Google Scholar
• Morales M, Iraola V, Leonor JR, et al. Different sensitization to storage mites depending on the co-exposure to house dust mites. Ann Allergy Asthma Immunol. 2015 Jan;114(1):36–42 e1.
   PubMed Web of Science ®Google Scholar
• Jeong KY, Lee JY, Son M, et al. Profiles of IgE sensitization to Der f 1, Der f 2, Der f 6, Der f 8, Der f 10, and Der f 20 in Korean house dust mite allergy patients. Allergy Asthma Immunol Res. 2015 Sept;7(5):483–488.
   PubMed Web of Science ®Google Scholar
• Dumez ME, Herman J, Campizi V, et al. Orchestration of an uncommon maturation cascade of the house dust mite protease allergen quartet. Front Immunol. 2014;5:138.
   PubMed Web of Science ®Google Scholar
• Jacquet A, Campisi V, Szpakowska M, et al. Profiling the extended cleavage specificity of the house dust mite protease allergens Der p 1, Der p 3 and Der p 6 for the prediction of new cell surface protein substrates. Int J Mol Sci. 2017 June 27;18:7.
   Web of Science ®Google Scholar
• Reithofer M, Jahn-Schmid B. Allergens with protease activity from house dust mites. Int J Mol Sci. 2017 June 27;18:7.
   Web of Science ®Google Scholar
• Posa D, Perna S, Resch Y, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol. 2017 Feb;139(2):541–549 e8.
   PubMed Web of Science ®Google Scholar
• Liao EC, Ho CM, Lin MY, et al. Dermatophagoides pteronyssinus and Tyrophagus putrescentiae allergy in allergic rhinitis caused by cross-reactivity not dual-sensitization. J Clin Immunol. 2010 Nov;30(6):830–839.
   PubMed Web of Science ®Google Scholar
• Kidon MI, Chiang WC, Liew WK, et al. Mite component-specific IgE repertoire and phenotypes of allergic disease in childhood: the tropical perspective. Pediatr Allergy Immunol. 2011 Mar;22(2):202–210.
   PubMed Web of Science ®Google Scholar
• Li B, Zou Z, Meng F, et al. Dust mite-derived Der f 3 activates a pro-inflammatory program in airway epithelial cells via PAR-1 and PAR-2. Mol Immunol. 2019;109:1–11.
   PubMed Web of Science ®Google Scholar
• Pulsawat P, Soongrung T, Satitsuksanoa P, et al. The house dust mite allergen Der p 5 binds lipid ligands and stimulates airway epithelial cells through a TLR2-dependent pathway. Clin Exp Allergy. 2019 Mar;49(3):378–390.
   PubMed Web of Science ®Google Scholar
• Santos da Silva E, Asam C, Lackner P, et al. Allergens of Blomia tropicalis: an overview of recombinant molecules. Int Arch Allergy Immunol. 2017;172(4):203–214.
   PubMed Web of Science ®Google Scholar
• Casset A, Mari A, Purohit A, et al. Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol. 2012;159(3):253–262.
   PubMed Web of Science ®Google Scholar
• Shek LP, Chong AR, Soh SE, et al. Specific profiles of house dust mite sensitization in children with asthma and in children with eczema. Pediatr Allergy Immunol. 2010 June;21(4 Pt 2):e718–22.
   PubMed Web of Science ®Google Scholar
• Pulsawat P, Theeraapisakkun M, Nony E, et al. Characterization of the house dust mite allergen Der p 21 produced in Pichia pastoris. Protein Expr Purif. 2014;101:8–13.
   PubMed Web of Science ®Google Scholar
• Shen HD, Chua KY, Lin WL, et al. Molecular cloning and immunological characterization of the house dust mite allergen Der f 7. Clin Exp Allergy. 1995 Oct;25(10):1000–1006.
   PubMed Web of Science ®Google Scholar
• Tsai JJ, Wang HC, Chiu CL, et al. The effect of Dermatophagoides pteronyssinus group 7 allergen (Der p 7) on dendritic cells and its role in T cell polarization. Immunobiology. 2016 Nov;221(11):1319–1328.
   PubMed Web of Science ®Google Scholar
• Huang CH, Liew LM, Mah KW, et al. Characterization of glutathione S-transferase from dust mite, Der p 8 and its immunoglobulin E cross-reactivity with cockroach glutathione S-transferase. Clin Exp Allergy. 2006 Mar;36(3):369–376.
   PubMed Web of Science ®Google Scholar
• Acevedo N, Mohr J, Zakzuk J, et al. Proteomic and immunochemical characterization of glutathione transferase as a new allergen of the nematode Ascaris lumbricoides. PLoS One. 2013;8(11):e78353.
   PubMed Web of Science ®Google Scholar
• Mueller GA, Pedersen LC, Glesner J, et al. Analysis of glutathione S-transferase allergen cross-reactivity in a North American population: relevance for molecular diagnosis. J Allergy Clin Immunol. 2015 Nov;136(5):1369–1377.
   PubMed Web of Science ®Google Scholar
• Weghofer M, Thomas WR, Kronqvist M, et al. Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest. 2008 Dec;38(12):959–965.
   PubMed Web of Science ®Google Scholar
• Park KH, Lee J, Lee JY, et al. Sensitization to various minor house dust mite allergens is greater in patients with atopic dermatitis than in those with respiratory allergic disease. Clin Exp Allergy. 2018 Aug;48(8):1050–1058.
   PubMed Web of Science ®Google Scholar
• Puerta L, Tudela JI, Munera M, et al. Specific IgE to Mite, Shrimp and Blo t 13 allergens in an allergic population from the Caribbean. J Allergy Clin Immunol. 2012 Feb 01;129(2, Supplement):AB167.
   Web of Science ®Google Scholar
• Matos Semedo F, Dorofeeva Y, Pires AP, et al. Der p 23 - clinical relevance of molecular monosensitisation in house dust mite allergy. J Investig Allergol Clin Immunol. 2019;8
   Google Scholar
• Resch Y, Blatt K, Malkus U, et al. Molecular, Structural and Immunological Characterization of Der p 18, a chitinase-like house dust mite allergen. PLoS One. 2016;11(8):e0160641.
   PubMed Web of Science ®Google Scholar
• Soongrung T, Mongkorntanyatip K, Peepim T, et al. The Blomia tropicalis allergen Blo t 7 stimulates innate immune signalling pathways through TLR2. Clin Exp Allergy. 2018 Apr;48(4):464–474.
   PubMed Web of Science ®Google Scholar
• Satitsuksanoa P, Kennedy M, Gilis D, et al. The minor house dust mite allergen Der p 13 is a fatty acid-binding protein and an activator of a TLR2-mediated innate immune response. Allergy. 2016 Oct;71(10):1425–1434.
   PubMed Web of Science ®Google Scholar
• Chevigne A, Jacquet A. Emerging roles of the protease allergen Der p 1 in house dust mite-induced airway inflammation. J Allergy Clin Immunol. 2018 Aug;142(2):398–400.
   PubMed Web of Science ®Google Scholar
• Schiermeier Q. Europe is a top destination for many researchers. Nature. 2019 May;569(7757):589–591.
   PubMedGoogle Scholar
• Beine M, Noël R, Ragot L. Determinants of the international mobility of students. Econ Edu Rev. 2014 Aug 0141:40–54.
   Web of Science ®Google Scholar
• Oliveira A, Freitas M. Motivations for international academic mobility: the perspective of university students and professors. Educação Em Revista. 2016;32:217–246.
   Google Scholar
• Wagner MR, Westaby JD. The willingness to relocate to another country: the impact of cultural similarity, destination safety, and financial incentive. Int J Psychol. 2009 Aug;44(4):257–265.
   PubMed Web of Science ®Google Scholar
• Laimer J, Hiebl-Flach J, Lengauer D, et al. MAESTROweb: a web server for structure-based protein stability prediction. Bioinformatics. 2016 May 01;32(9):1414–1416.
   PubMed Web of Science ®Google Scholar
• Di Felice G, Colombo P. Nanoparticle-allergen complexes for allergen immunotherapy. Int J Nanomedicine. 2017;12:4493–4504.
   PubMed Web of Science ®Google Scholar
• Nascimento Santos L, Carvalho Pacheco LG, Silva Pinheiro C, et al. Recombinant proteins of helminths with immunoregulatory properties and their possible therapeutic use. Acta Trop. 2017 Feb;166:202–211.
   PubMed Web of Science ®Google Scholar
• Blanco C, Bazire R, Argiz L, et al. Sublingual allergen immunotherapy for respiratory allergy: a systematic review. Drugs Context. 2018;7:212552.
   PubMedGoogle Scholar